Statements (24)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:academic_journal
|
gptkbp:abbreviation |
gptkb:CNS_Drugs
|
gptkbp:country |
gptkb:New_Zealand
|
gptkbp:discipline |
gptkb:pharmacy
|
gptkbp:editor |
gptkb:Kate_Palmer
|
gptkbp:established |
1994
|
gptkbp:focus |
central nervous system drugs
|
gptkbp:frequency |
monthly
|
https://www.w3.org/2000/01/rdf-schema#label |
CNS Drugs
|
gptkbp:impact |
2022
6.497 |
gptkbp:ISSN |
1172-7047
1179-1934 |
gptkbp:language |
English
|
gptkbp:openAccess |
hybrid
|
gptkbp:peerReviewed |
yes
|
gptkbp:publisher |
gptkb:Springer_Nature
gptkb:Adis_International |
gptkbp:subjectArea |
neurology
psychiatry clinical pharmacology |
gptkbp:website |
https://www.springer.com/journal/40263
|
gptkbp:bfsParent |
gptkb:Adis_International
|
gptkbp:bfsLayer |
7
|